Insulin-induced enhancement of antitumoral response to methotrexate in breast cancer patients

Cancer Chemotherapy and Pharmacology

Volumn 53, Issue 3, 2004, Pages 220-224

  Lasalvia Prisco, Eduardo ^a,b,c,d   Cucchi, Silvia ^b,d   Vázquez, Jesús ^b,c   Lasalvia Galante, Eduardo ^b,c   Golomar, Wilson ^b,c   Gordon, William ^d  

^a UNIVERSITY OF URUGUAY   (Uruguay)

^b Interdoctors   (Uruguay)

^c National Cancer Institute   (Uruguay)

^d PharmaBlood Inc   (United States)

Author keywords

Breast cancer; Chemotherapy; Insulin; Methotrexate; Tumor growth

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; INSULIN; METHOTREXATE;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST TUMOR; CANCER RESISTANCE; CELL DIVISION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXICITY; DISEASE COURSE; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; DRUG RESISTANCE; FEMALE; HUMAN; IN VITRO STUDY; MEDICAL ASSESSMENT; METASTASIS; MULTICENTER STUDY; PATHOLOGY; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SOLID TUMOR; STATISTICAL ANALYSIS;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; CELL DIVISION; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INSULIN; METHOTREXATE; MIDDLE AGED;

EID: 1442286477     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-003-0716-7     Document Type: Article

References (13)

1. Alabaster A, Vonderhaar B, Shafie S (1981) Metabolic modification by insulin enhances methotrexate cytotoxicity in MCF-7 human breast cancer cells. Eur J Cancer Clin Oncol 17:1223-1228
2. Ayre SG, Perez Garcia y Bellon D, Perez Garcia D Jr (1990) Neoadjuvant low-dose chemotherapy with Insulin in breast carcinomas. Eur J Cancer 26:1262-1263
3. Cardoso F, Di LA, Lohrisch C, Bernard C, Ferreira F, Piccart M (2002) Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades. Ann Oncol 13:197-207
4. Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N (1990) Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 50:48-53
5. Gross GE, Boldt DH, Osborne CK (1984) Perturbation by insulin of human breast cancer cell kinetics. Cancer Res 44:3570-3575
6. Kath R, Schiel R, Muller UA, Hoffken K (2000) Malignancies in patients with insulin-treated diabetes mellitus. J Cancer Res Clin Oncol 126:412-417
7. Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR (2002) Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol 156:349-352
8. Osborne CK, Bolan G, Monaco ME, Lippman ME (1976) Hormone responsive human breast cancer in long-term tissue culture: effect of insulin. Proc Natl Acad Sci U S A 73:4536-4540
9. Oster JB, Creasey WA (1981) Enhancement of cellular uptake of ellipticine by insulin preincubation. Eur J Cancer Clin Oncol 17:1097-1103
10. Schilsky RL, Bailey BD, Chabner BA (1981) Characteristics of membrane transport of methotrexate by cultured human breast cancer cells. Biochem Pharmacol 30:1537-1542
11. Shackney SE, McCormack GW, Cocheral GJ (1978) Growth rate patterns of solid tumors and their relation to responsiveness to therapy. Ann Intern Med 89:107-121
12. Silva JM, Garcia JM, Dominguez G, Silva J, Rodriguez R, Portero JL, Corbacho C, Provencio M, Espana P, Bonilla F Silva JM, Garcia JM, Dominguez G, et al (2000) DNA damage after chemotherapy correlates with tumor response and survival in small cell lung cancer patients. Mutat Res 456:65-71
13. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216